Form4insider filings, from the source

SEC Form 4 · accession 0001104659-17-018125

Amphastar Pharmaceuticals, Inc. · AMPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mary Z. Luo
Officer — COO, Chief Scientist, Chairman · Director · 10% Owner
Jack Y. Zhang
Officer — CEO & Chief Scientific Officer · Director · 10% Owner
Period of report
Mar 16, 2017
Accepted (ET)
Mar 20, 2017 · 8:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 16, 2017A156,554$0.00A1,244,889D
Common StockF2Mar 17, 2017F23,108$13.75D1,221,781D
Common StockF1,F3Mar 16, 2017A67,415$0.00A819,736ISee footnote
Common StockF2,F3Mar 17, 2017F9,951$13.75D809,785ISee footnote
Common StockF4holding———7,461,594ISee footnote
Common StockF5holding———5,000ISee footnote
Common StockF6holding———200,000ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F7$14.69Mar 16, 2017A490,477A—Mar 16, 2025Common Stock490,477490,477D
Employee Stock Option (right to buy)F3,F7$14.69Mar 16, 2017A211,213A—Mar 16, 2025Common Stock211,213211,213I

Explanation of responses